MAIA Biotechnology (MAIA) Interest Expenses (2021 - 2024)
MAIA Biotechnology's (MAIA) quarterly Interest Expenses came in at -$28.0 in Q4 2024, down 132.94% quarter-over-quarter from $85.0 in Q3 2024.
Analysis
MAIA Biotechnology (MAIA) Interest Expenses (2021 - 2024) Analysis & Trends
MAIA Biotechnology (MAIA) has reported Interest Expenses for 4 consecutive years, with -$28.0 the latest figure, recorded in Q4 2024.
- On a quarterly basis, Interest Expenses changed N/A year-over-year to -$28.0 in Q4 2024; TTM through Dec 2024 was $58.0, a 99.15% decrease from a year earlier, with the FY2024 full-year figure at $57.0, down 99.17% from the prior year.
- Interest Expenses was -$28.0 for Q4 2024 at MAIA Biotechnology, down from $85.0 in the prior quarter.
- Over five years, Interest Expenses peaked at $451306.0 in Q3 2021 and troughed at -$28.0 in Q4 2024.
- A 4-year average of $77865.9 and a median of $1715.5 in 2022 frame the typical range for Interest Expenses.
- Across the five-year window, Interest Expenses tumbled 99.97% in 2022 and jumped 8400.0% in 2024, its largest moves.
- Over 4 years, Interest Expenses stood at $451306.0 in 2021, then tumbled by 98.86% to $5147.0 in 2022, then slumped by 99.98% to $1.0 in 2023, then plunged by 2900.0% to -$28.0 in 2024.
- The last three Interest Expenses figures came in at -$28.0 (Q4 2024), $85.0 (Q3 2024), and $1.0 (Q3 2023), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 673.00 Mn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 247.00 Mn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 11.00 Mn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | -1.00 Mn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 82.05 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | MAIA Biotechnology | 79.34 Mn | 51.74 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -28.00 |
| Sep 30, 2024 | 85.00 |
| Sep 30, 2023 | 1.00 |
| Jun 30, 2023 | 1,715.00 |
| Mar 31, 2023 | 5,147.00 |
| Dec 31, 2022 | 5,147.00 |
| Sep 30, 2022 | 1,716.00 |
| Jun 30, 2022 | 104.00 |
| Sep 30, 2021 | 451,306.00 |
| Jun 30, 2021 | 313,466.00 |